Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis

NCT00603785 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Insufficient funds available

Conditions

Chronic Sinusitis

Interventions

DRUG: Placebo
DRUG: Xolair

Sponsor

University of California, San Francisco

Collaborators

[object Object]